Gary Roberts

Cannabis access is associated with reduced rates of opioid use and abuse, opioid-related hospitalizations, opioid-related traffic fatalities, opioid-related drug treatment admissions, and opioid-related overdose deaths “In all, 178 patients with chronic pain were treated for a period of 366 days (median; range 31-2590 days). Median age was 72 years (26-96 years). 115 patients (65%) with

Psychedelic therapy: a roadmap for wider acceptance and utilization Mason Marks & I. Glenn Cohen  Nature Medicine volume 27, pages1669–1671 (2021)Cite this article Psychedelics have shown great promise in treating mental-health conditions, but their use is severely limited by legal obstacles, which could be overcome. The COVID-19 pandemic has exacerbated a national mental-health crisis in the United States. For two

Johns Hopkins Study Shows Psilocybin Effective for a Year  by Jason NajumFebruary 16, 2022 in Breaking News, Science Reading Time: 2 mins read  A new study by Johns Hopkins Medicine shows that the antidepressant effects of psilocybin (with psychotherapy) can last at least a year after treatment. This was a follow-up to previous studies by Johns Hopkins that showed positive results for

BY NORML POSTED ON OCTOBER 21, 2021 Watford, United Kingdom: The daily consumption of cannabinoid extracts is associated with tumor regression in an elderly patient with lung cancer, according to a case study published in the journal BMJ Case Reports.  British investigators reported on the case of a woman in her 80s diagnosed with a cancerous tumor in her lungs. She

BY NORML POSTED ON JANUARY 13, 2022 Portland, OR: A significant percentage of health care practitioners possess only limited knowledge about the use and efficacy of medical cannabis, according to survey data published in the Journal of the American Association of Nurse Practitioners.  A team of investigators affiliated with the Oregon Health & Science University surveyed 178 health care professionals (physicians,

Cannabis access is associated with reduced rates of opioid use and abuse, opioid-related hospitalizations, opioid-related traffic fatalities, opioid-related drug treatment admissions, and opioid-related overdose deaths “In this study involving patients with chronic musculoskeletal noncancer back pain certified for MC, opioid prescriptions filled significantly decreased after MC [medicinal cannabis] certification. … [P]atients in the less than

The majority of medical clinicians and students endorse the use of cannabis as a therapeutic treatment option Nationwide survey data compiled by researchers affiliated with the US Centers for Disease Control and Prevention reported that nearly seven-in-ten practicing medical professionals supported the use of medical cannabis. Those who favored its medical use of were most

AP Feb 1, 2002 The NFL is awarding $1 million in research funding to two teams of medical researchers to study the effects of cannabinoids on pain management and neuroprotection from concussion in elite football players. Medical teams from the University of California San Diego and University of Regina in Canada were selected from 106 proposals

By Mattha Busby; illustrated by Nicoletta Belardinelli For more than 15 years, Ainslie Course suffered from one of the most intense pains known to humans: cluster headaches. Sometimes nicknamed “suicide headaches”, her main symptom was an excruciating pain that suddenly surrounded one eye in debilitating bouts of attacks. These cycles could last for months, and acute sufferers are